rovalpituzumab tesirine
abbvie
['rovat', 'sclc', 'rova,(-approval),(-microvascular)']
beautiful sclc plots in phase 1 trial of dll3 bite. #asco23 #sclc hopefully, better fate than rovat 
Hem/Onc fellow at @karmanoscancer. Alum @AlbanyMed
 @mcgillu. AΩA. GI Oncology Mednet Associate Editor.